Stewart WF, Wood C, Reed ML, Roy J, Lipton RB. Cumulative lifetime migraine incidence in women and men. Cephalalgia : an international journal of headache. 2008;28(11):1170–8.
CAS
Article
PubMed
Google Scholar
Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (London, England). 2015;386(9995):743–800.
Article
Google Scholar
Hepp Z, Dodick DW, Varon SF, Gillard P, Hansen RN, Devine EB. Adherence to oral migraine-preventive medications among patients with chronic migraine. Cephalalgia : an international journal of headache. 2015;35(6):478–88.
Article
PubMed
Google Scholar
Goadsby PJ, Sprenger T. Current practice and future directions in the prevention and acute management of migraine. The Lancet Neurology. 2010;9(3):285–98.
Article
PubMed
Google Scholar
Wells RE, Bertisch SM, Buettner C, Phillips RS, McCarthy EP. Complementary and alternative medicine use among adults with migraines/severe headaches. Headache. 2011;51(7):1087–97.
Article
PubMed
PubMed Central
Google Scholar
Welch KM, Levine SR, D'Andrea G, Schultz LR, Helpern JA. Preliminary observations on brain energy metabolism in migraine studied by in vivo phosphorus 31 NMR spectroscopy. Neurology. 1989;39(4):538–41.
CAS
Article
PubMed
Google Scholar
Barbiroli B, Montagna P, Cortelli P, Funicello R, Iotti S, Monari L, et al. Abnormal brain and muscle energy metabolism shown by 31P magnetic resonance spectroscopy in patients affected by migraine with aura. Neurology. 1992;42(6):1209.
CAS
Article
PubMed
Google Scholar
Watanabe H, Kuwabara T, Ohkubo M, Tsuji S, Yuasa T. Elevation of cerebral lactate detected by localized 1H-magnetic resonance spectroscopy in migraine during the interictal period. Neurology. 1996;47(4):1093–5.
CAS
Article
PubMed
Google Scholar
Schoenen J, Jacquy J, Lenaerts M. Effectiveness of high-dose riboflavin in migraine prophylaxis A randomized controlled trial. Neurology. 1998;50(2):466–70.
CAS
Article
PubMed
Google Scholar
MacLennan SC, Wade FM, Forrest KM, Ratanayake PD, Fagan E, Antony J. High-dose riboflavin for migraine prophylaxis in children: a double-blind, randomized, placebo-controlled trial. Journal of child neurology. 2008;23(11):1300–4.
Article
PubMed
Google Scholar
Athaillah YD, Saing JH, Saing HB, Lelo A. Riboflavin as migraine prophylaxis in adolescents. Paediatr Indones. 2012;52:132–7.
Article
Google Scholar
Maizels M, Blumenfeld A, Burchette R. A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial. Headache. 2004;44(9):885–90.
Article
PubMed
Google Scholar
Gaul C, Diener HC, Danesch U. Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, double-blind, multicenter trial. J Headache Pain. 2015;16:516.
Article
PubMed
Google Scholar
Di Lorenzo C, Pierelli F, Coppola G, Grieco GS, Rengo C, Ciccolella M, et al. Mitochondrial DNA haplogroups influence the therapeutic response to riboflavin in migraineurs. Neurology. 2009;72(18):1588–94.
Article
PubMed
Google Scholar
Sandor PS, Di Clemente L, Coppola G, Saenger U, Fumal A, Magis D, et al. Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial. Neurology. 2005;64(4):713–5.
CAS
Article
PubMed
Google Scholar
Slater SK, Nelson TD, Kabbouche MA, LeCates SL, Horn P, Segers A, et al. A randomized, double-blinded, placebo-controlled, crossover, add-on study of CoEnzyme Q10 in the prevention of pediatric and adolescent migraine. Cephalalgia : an international journal of headache. 2011;31(8):897–905.
Article
Google Scholar
Welch KM, Ramadan NM. Mitochondria, magnesium and migraine. Journal of the neurological sciences. 1995;134(1–2):9–14.
CAS
Article
PubMed
Google Scholar
Gallai V, Sarchielli P, Coata G, Firenze C, Morucci P, Abbritti G. Serum and salivary magnesium levels in migraine. Results in a group of juvenile patients. Headache. 1992;32(3):132–5.
CAS
Article
PubMed
Google Scholar
Gallai V, Sarchielli P, Morucci P, Abbritti G. Red blood cell magnesium levels in migraine patients. Cephalalgia : an international journal of headache. 1993;13(2):94–81; discussion 73.
CAS
Article
PubMed
Google Scholar
Mauskop A, Altura BT, Altura BM. Serum ionized magnesium levels and serum ionized calcium/ionized magnesium ratios in women with menstrual migraine. Headache. 2002;42(4):242–8.
Article
PubMed
Google Scholar
Taylor FR. Nutraceuticals and headache: the biological basis. Headache. 2011;51(3):484–501.
Article
PubMed
Google Scholar
Facchinetti F, Sances G, Borella P, Genazzani AR, Nappi G. Magnesium prophylaxis of menstrual migraine: effects on intracellular magnesium. Headache. 1991;31(5):298–301.
CAS
Article
PubMed
Google Scholar
Taubert K. [Magnesium in migraine. Results of a multicenter pilot study]. Fortschritte der Medizin. 1994;112(24):328–30.
CAS
PubMed
Google Scholar
von Luckner A, Riederer F. Magnesium in Migraine Prophylaxis-Is There an Evidence-Based Rationale? A Systematic Review. Headache. 2018;58(2):199–209.
Article
Google Scholar
Pfaffenrath V, Wessely P, Meyer C, Isler HR, Evers S, Grotemeyer KH, et al. Magnesium in the prophylaxis of migraine--a double-blind placebo-controlled study. Cephalalgia : an international journal of headache. 1996;16(6):436–40.
CAS
Article
PubMed
Google Scholar
Peikert A, Wilimzig C, Kohne-Volland R. Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia : an international journal of headache. 1996;16(4):257–63.
CAS
Article
Google Scholar
Koseoglu E, Talaslioglu A, Gonul AS, Kula M. The effects of magnesium prophylaxis in migraine without aura. Magnesium research. 2008;21(2):101–8.
CAS
PubMed
Google Scholar
Rajapakse T, Pringsheim T. Nutraceuticals in Migraine: A Summary of Existing Guidelines for Use. Headache. 2016;56(4):808–16.
Article
PubMed
Google Scholar
Lipton RB, Gobel H, Einhaupl KM, Wilks K, Mauskop A. Petasites hybridus root (butterbur) is an effective preventive treatment for migraine. Neurology. 2004;63(12):2240–4.
CAS
Article
PubMed
Google Scholar
Diener HC, Rahlfs VW, Danesch U. The first placebo-controlled trial of a special butterbur root extract for the prevention of migraine: reanalysis of efficacy criteria. European neurology. 2004;51(2):89–97.
CAS
Article
PubMed
Google Scholar
Diener HC, Pfaffenrath V, Schnitker J, Friede M, Henneicke-von Zepelin HH. Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention--a randomized, double-blind, multicentre, placebo-controlled study. Cephalalgia : an international journal of headache. 2005;25(11):1031–41.
CAS
Article
Google Scholar
Pfaffenrath V, Diener HC, Fischer M, Friede M, Henneicke-von Zepelin HH. The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis--a double-blind, multicentre, randomized placebo-controlled dose-response study. Cephalalgia : an international journal of headache. 2002;22(7):523–32.
CAS
Article
PubMed
Google Scholar
Goslin RE, Gray RN, McCrory DC, Penzien D, Rains J, Hasselblad V. AHRQ Technical Reviews. Behavioral and Physical Treatments for Migraine Headache. Rockville (MD): Agency for Health Care Policy and Research (US); 1999.
Google Scholar
Penzien DB, Irby MB, Smitherman TA, Rains JC, Houle TT. Well-Established and Empirically Supported Behavioral Treatments for Migraine. Current pain and headache reports. 2015;19(7):34.
Article
PubMed
Google Scholar
Silberstein SD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2000;55(6):754–62.
CAS
Article
PubMed
Google Scholar
Holroyd KA, Cottrell CK, O'Donnell FJ, Cordingley GE, Drew JB, Carlson BW, et al. Effect of preventive (beta blocker) treatment, behavioural migraine management, or their combination on outcomes of optimised acute treatment in frequent migraine: randomised controlled trial. BMJ (Clinical research ed). 2010;341:c4871.
Google Scholar
Powers SW, Kashikar-Zuck SM, Allen JR, et al. Cognitive behavioral therapy plus amitriptyline for chronic migraine in children and adolescents: A randomized clinical trial. Jama. 2013;310(24):2622–30.
CAS
Article
PubMed
PubMed Central
Google Scholar
Grazzi L, Andrasik F, D'Amico D, Leone M, Usai S, Kass SJ, et al. Behavioral and pharmacologic treatment of transformed migraine with analgesic overuse: outcome at 3 years. Headache. 2002;42(6):483–90.
Article
PubMed
Google Scholar
Rausa M, Palomba D, Cevoli S, Lazzerini L, Sancisi E, Cortelli P, et al. Biofeedback in the prophylactic treatment of medication overuse headache: a pilot randomized controlled trial. J Headache Pain. 2016;17(1):87.
Article
PubMed
PubMed Central
Google Scholar
Linde K, Allais G, Brinkhaus B, Fei Y, Mehring M, Vertosick EA, et al. Acupuncture for the prevention of episodic migraine. The Cochrane database of systematic reviews. 2016(6):Cd001218.
Zhao L, Chen J, Li Y, et al. The long-term effect of acupuncture for migraine prophylaxis: A randomized clinical trial. JAMA Internal Medicine. 2017.
Linde K, Streng A, Jurgens S, Hoppe A, Brinkhaus B, Witt C, et al. Acupuncture for patients with migraine: a randomized controlled trial. Jama. 2005;293(17):2118–25.
CAS
Article
PubMed
Google Scholar
Diener HC, Kronfeld K, Boewing G, Lungenhausen M, Maier C, Molsberger A, et al. Efficacy of acupuncture for the prophylaxis of migraine: a multicentre randomised controlled clinical trial. The Lancet Neurology. 2006;5(4):310–6.
Article
PubMed
Google Scholar
Gérardy PY, Fabry D, Fumal A, Schoenen J. A pilot study on supra-orbital surface electrotherapy in migraine. Cephalalgia : an international journal of headache. 2009(29):134.
Google Scholar
Schoenen J, Vandersmissen B, Jeangette S, Herroelen L, Vandenheede M, Gerard P, et al. Migraine prevention with a supraorbital transcutaneous stimulator: a randomized controlled trial. Neurology. 2013;80(8):697–704.
Article
PubMed
Google Scholar
Magis D, Sava S, d'Elia TS, Baschi R, Schoenen J. Safety and patients' satisfaction of transcutaneous supraorbital neurostimulation (tSNS) with the Cefaly(R) device in headache treatment: a survey of 2,313 headache sufferers in the general population. J Headache Pain. 2013;14:95.
Article
PubMed
PubMed Central
Google Scholar
Liu Y, Dong Z, Wang R, Ao R, Han X, Tang W, et al. Migraine prevention using different frequencies of transcutaneous occipital nerve stimulation: A randomized controlled trial. The journal of pain : official journal of the American Pain Society. 2017.
Schoenen J, D'Ostilio K, Cosseddu A, Nonis R, Sava S, Magis D. Transcranial Direct Current Stimulation and Transcutaneous Occipital Nerve Stimulation in Chronic Migraine: A Pilot-Comparison of Therapeutic and Electrophysiological Effects. Neurology. 2016;86(16 Supplement P2.200).
Sadler RM, Purdy RA, Rahey S. Vagal nerve stimulation aborts migraine in patient with intractable epilepsy. Cephalalgia : an international journal of headache. 2002;22(6):482–4.
CAS
Article
Google Scholar
Goadsby PJ, Grosberg BM, Mauskop A, Cady R, Simmons KA. Effect of noninvasive vagus nerve stimulation on acute migraine: an open-label pilot study. Cephalalgia : an international journal of headache. 2014;34(12):986–93.
CAS
Article
PubMed
Google Scholar
Barbanti P, Grazzi L, Egeo G, Padovan AM, Liebler E, Bussone G. Non-invasive vagus nerve stimulation for acute treatment of high-frequency and chronic migraine: an open-label study. J Headache Pain. 2015;16:61.
Article
PubMed
PubMed Central
Google Scholar
Magis D, Gerard P, Schoenen J. Transcutaneous Vagus Nerve Stimulation (tVNS) for headache prophylaxis: initial experience. J Headache Pain. 2013;14(Suppl 1):198.
Article
Google Scholar
Grazzi L, Egeo G, Calhoun AH, McClure CK, Liebler E, Barbanti P. Non-invasive Vagus Nerve Stimulation (nVNS) as mini-prophylaxis for menstrual/menstrually related migraine: an open-label study. J Headache Pain. 2016;17(1).
Silberstein SD, Calhoun AH, Lipton RB, Grosberg BM, Cady RK, Dorlas S, et al. Chronic migraine headache prevention with noninvasive vagus nerve stimulation: The EVENT study. Neurology. 2016;87(5):529–38.
Article
PubMed
PubMed Central
Google Scholar
Straube A, Ellrich J, Eren O, Blum B, Ruscheweyh R. Treatment of chronic migraine with transcutaneous stimulation of the auricular branch of the vagal nerve (auricular t-VNS): a randomized, monocentric clinical trial. J Headache Pain. 2015;16:543.
Article
PubMed
Google Scholar
Andreou AP, Holland PR, Akerman S, Summ O, Fredrick J, Goadsby PJ. Transcranial magnetic stimulation and potential cortical and trigeminothalamic mechanisms in migraine. Brain : a journal of neurology. 2016;139(Pt 7):2002–14.
Article
Google Scholar
Clarke BM, Upton AR, Kamath MV, Al-Harbi T, Castellanos CM. Transcranial magnetic stimulation for migraine: clinical effects. J Headache Pain. 2006;7(5):341–6.
Article
PubMed
PubMed Central
Google Scholar
Lipton RB, Dodick DW, Silberstein SD, Saper JR, Aurora SK, Pearlman SH, et al. Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial. The Lancet Neurology. 2010;9(4):373–80.
Article
PubMed
Google Scholar
Bhola R, Kinsella E, Giffin N, Lipscombe S, Ahmed F, Weatherall M, et al. Single-pulse transcranial magnetic stimulation (sTMS) for the acute treatment of migraine: evaluation of outcome data for the UK post market pilot program. J Headache Pain. 2015;16:535.
Article
PubMed
Google Scholar
Bruggenjurgen B, Baker T, Bhogal R, Ahmed F. Cost impact of a non-invasive, portable device for patient self-administration of chronic migraine in a UK National Health Service setting. SpringerPlus. 2016;5(1):1249.
CAS
Article
PubMed
PubMed Central
Google Scholar
Antal A, Kriener N, Lang N, Boros K, Paulus W. Cathodal transcranial direct current stimulation of the visual cortex in the prophylactic treatment of migraine. Cephalalgia : an international journal of headache. 2011;31(7):820–8.
Article
Google Scholar
Rocha S, Melo L, Boudoux C, Foerster A, Araujo D, Monte-Silva K. Transcranial direct current stimulation in the prophylactic treatment of migraine based on interictal visual cortex excitability abnormalities: A pilot randomized controlled trial. Journal of the neurological sciences. 2015;349(1–2):33–9.
Article
PubMed
Google Scholar
Auvichayapat P, Janyacharoen T, Rotenberg A, Tiamkao S, Krisanaprakornkit T, Sinawat S, et al. Migraine prophylaxis by anodal transcranial direct current stimulation, a randomized, placebo-controlled trial. Journal of the Medical Association of Thailand = Chotmaihet thangphaet. 2012;95(8):1003–12.
PubMed
Google Scholar
Dasilva AF, Mendonca ME, Zaghi S, Lopes M, Dossantos MF, Spierings EL, et al. tDCS-induced analgesia and electrical fields in pain-related neural networks in chronic migraine. Headache. 2012;52(8):1283–95.
Article
PubMed
PubMed Central
Google Scholar
Vigano A, D'Elia TS, Sava SL, Auve M, De Pasqua V, Colosimo A, et al. Transcranial Direct Current Stimulation (tDCS) of the visual cortex: a proof-of-concept study based on interictal electrophysiological abnormalities in migraine. J Headache Pain. 2013;14:23.
Article
PubMed
PubMed Central
Google Scholar
Wang J, Dong WW, Zhang WH, Zheng J, Wang X. Electrical stimulation of cerebellar fastigial nucleus: mechanism of neuroprotection and prospects for clinical application against cerebral ischemia. CNS neuroscience & therapeutics. 2014;20(8):710–6.
CAS
Article
Google Scholar
Juan Y, Shu O, Jinhe L, Na Y, Yushuang D, Weiwei D, et al. Migraine prevention with percutaneous mastoid electrical stimulator: A randomized double-blind controlled trial. Cephalalgia : an international journal of headache. 2016.
Yarnitsky D, Volokh L, Ironi A, Weller B, Shor M, Shifrin A, et al. Nonpainful remote electrical stimulation alleviates episodic migraine pain. Neurology. 2017;88(13):1250–5.
Article
PubMed
Google Scholar
Bartsch T, Goadsby PJ. The trigeminocervical complex and migraine: current concepts and synthesis. Current pain and headache reports. 2003;7(5):371–6.
CAS
Article
PubMed
Google Scholar
Bartsch T, Goadsby PJ. Stimulation of the greater occipital nerve induces increased central excitability of dural afferent input. Brain : a journal of neurology. 2002;125(Pt 7):1496–509.
Article
Google Scholar
Lipton R, Goadsby PJ, Cady R, Aurora SK, Grosberg BM, Freitag F. PRISM study: occipital nerve stimulation for treatment-refractory migraine [abstract PO47]. Cephalalgia : an international journal of headache. 2009;29.
Saper JR, Dodick DW, Silberstein SD, McCarville S, Sun M, Goadsby PJ. Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study. Cephalalgia : an international journal of headache. 2011;31(3):271–85.
Article
Google Scholar
Silberstein SD, Dodick DW, Saper J, Huh B, Slavin KV, Sharan A, et al. Safety and efficacy of peripheral nerve stimulation of the occipital nerves for the management of chronic migraine: results from a randomized, multicenter, double-blinded, controlled study. Cephalalgia : an international journal of headache. 2012;32(16):1165–79.
Article
Google Scholar
Chen YF, Bramley G, Unwin G, Hanu-Cernat D, Dretzke J, Moore D, et al. Occipital Nerve Stimulation for Chronic Migraine—A Systematic Review and Meta-Analysis. PloS one. 2015;10(3).
Goadsby PJ, Lipton RB. A review of paroxysmal hemicranias, SUNCT syndrome and other short-lasting headaches with autonomic feature, including new cases. Brain : a journal of neurology. 1997;120 ( Pt 1):193–209.
Article
Google Scholar
Goadsby PJ, Lipton RB, Ferrari MD. Migraine--current understanding and treatment. The New England journal of medicine. 2002;346(4):257–70.
CAS
Article
PubMed
Google Scholar
Maizels M, Geiger AM. Intranasal lidocaine for migraine: a randomized trial and open-label follow-up. Headache. 1999;39(8):543–51.
CAS
Article
PubMed
Google Scholar
Tepper SJ, Rezai A, Narouze S, Steiner C, Mohajer P, Ansarinia M. Acute treatment of intractable migraine with sphenopalatine ganglion electrical stimulation. Headache. 2009;49(7):983–9.
Article
PubMed
Google Scholar
De Agostino R, Federspiel B, Cesnulis E, Sandor PS. High-cervical spinal cord stimulation for medically intractable chronic migraine. Neuromodulation : journal of the International Neuromodulation Society. 2015;18(4):289–96; discussion 96.
Arcioni R, Palmisani S, Mercieri M, Vano V, Tigano S, Smith T, et al. Cervical 10 kHz spinal cord stimulation in the management of chronic, medically refractory migraine: A prospective, open-label, exploratory study. European journal of pain (London, England). 2016;20(1):70–8.
CAS
Article
Google Scholar